BaijayantaMaitiMDPhD
Neurology • Saint Louis, MOMovement Disorder, Neuromuscular Medicine
Associate Professor of Neurology and Radiology Program Director, Movement Disorders Fellowship Barnes-Jewish Hospital / Washington University in St. Louis School of Medicine.
Dr. Maiti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
517 S Euclid Ave
# Dv
Saint Louis, MO 63110Phone+1 314-362-1408Fax+1 314-362-3752
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Neuromuscular Medicine (Neurology), 2014 - 2016
Washington University/B-JH/SLCH ConsortiumFellowship, Neuromuscular Medicine (Neurology), 2013 - 2014- Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2009 - 2013
- University of UtahPhD, Human Genetics, 2003 - 2009
Medical College and Hospital KolkataClass of 2003
Certifications & Licensure
IL State Medical License 2021 - 2026
MO State Medical License 2013 - 2025- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Publications & Presentations
PubMed
- 26 citationsIs Levodopa Response a Valid Indicator of Parkinson's Disease?W.R. Wayne Martin, Michael Miles, Qiaonan Zhong, Johanna M Hartlein, Brad A. Racette
Movement Disorders. 2021-04-01 - 69 citationsClinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1Joachim Schessl, A.L. Taratuto, Caroline Sewry, Roberta Battini, Steven S. Chin
Brain. 2009-02-01 - 112 citationsProteomic identification of FHL1 as the protein mutated in human reducing body myopathyJoachim Schessl, Yaqun Zou, Meagan Jane Mcgrath, Belinda S. Cowling, Baijayanta Maiti
The Journal of Clinical Investigation. 2008-03-03
Press Mentions
Blood Pressure Medicine Dynacirc Falls Short in Phase 3 Trial for Early Parkinson’sApril 2nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
